BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33119478)

  • 1. B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
    Modak S; Zanzonico P; Grkovski M; Slotkin EK; Carrasquillo JA; Lyashchenko SK; Lewis JS; Cheung IY; Heaton T; LaQuaglia MP; Cheung NV; Pandit-Taskar N
    J Clin Oncol; 2020 Dec; 38(36):4283-4291. PubMed ID: 33119478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and Radiation Dosimetry of Intraperitoneally Administered
    Grkovski M; Modak S; Zanzonico PB; Carrasquillo JA; Larson SM; Humm JL; Pandit-Taskar N
    J Nucl Med; 2022 Jul; 63(7):1094-1100. PubMed ID: 34857661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 study of intraventricular
    Kramer K; Pandit-Taskar N; Kushner BH; Zanzonico P; Humm JL; Tomlinson U; Donzelli M; Wolden SL; Haque S; Dunkel I; Souweidane MM; Greenfield JP; Tickoo S; Lewis JS; Lyashchenko SK; Carrasquillo JA; Chu B; Horan C; Larson SM; Cheung NV; Modak S
    J Hematol Oncol; 2022 Nov; 15(1):165. PubMed ID: 36371226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy.
    Kramer K; Donzelli MA; Pessin MS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2411-2414. PubMed ID: 33533945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and Dosimetry of Intraventricularly Administered
    Pandit-Taskar N; Zanzonico PB; Kramer K; Grkovski M; Fung EK; Shi W; Zhang Z; Lyashchenko SK; Fung AM; Pentlow KS; Carrasquillo JA; Lewis JS; Larson SM; Cheung NV; Humm JL
    J Nucl Med; 2019 Dec; 60(12):1794-1801. PubMed ID: 31405921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.
    Bailey K; Pandit-Taskar N; Humm JL; Zanzonico P; Gilheeney S; Cheung NV; Kramer K
    J Neurooncol; 2019 May; 143(1):101-106. PubMed ID: 30879172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
    Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IntraOmmaya compartmental radioimmunotherapy using
    Yerrabelli RS; He P; Fung EK; Kramer K; Zanzonico PB; Humm JL; Guo H; Pandit-Taskar N; Larson SM; Cheung NV
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1166-1177. PubMed ID: 33047248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.
    Boudousq V; Ricaud S; Garambois V; Bascoul-Mollevi C; Boutaleb S; Busson M; Quenet F; Colombo PE; Bardiès M; Kotzki PO; Navarro-Teulon I; Pèlegrin A; Pouget JP
    J Nucl Med; 2010 Nov; 51(11):1748-55. PubMed ID: 20956481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
    Kaminski MS; Fig LM; Zasadny KR; Koral KF; DelRosario RB; Francis IR; Hanson CA; Normolle DP; Mudgett E; Liu CP
    J Clin Oncol; 1992 Nov; 10(11):1696-711. PubMed ID: 1403053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors.
    Tap WD; Demetri G; Barnette P; Desai J; Kavan P; Tozer R; Benedetto PW; Friberg G; Deng H; McCaffery I; Leitch I; Badola S; Chang S; Zhu M; Tolcher A
    J Clin Oncol; 2012 May; 30(15):1849-56. PubMed ID: 22508822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review.
    Reijers SJM; Siew CCH; Kok NFM; Honoré C; van Houdt WJ
    Curr Oncol; 2023 Mar; 30(4):3951-3963. PubMed ID: 37185412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
    Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial.
    Hayes-Jordan AA; Coakley BA; Green HL; Xiao L; Fournier KF; Herzog CE; Ludwig JA; McAleer MF; Anderson PM; Huh WW
    Ann Surg Oncol; 2018 Apr; 25(4):872-877. PubMed ID: 29383611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Wiseman GA; White CA; Sparks RB; Erwin WD; Podoloff DA; Lamonica D; Bartlett NL; Parker JA; Dunn WL; Spies SM; Belanger R; Witzig TE; Leigh BR
    Crit Rev Oncol Hematol; 2001; 39(1-2):181-94. PubMed ID: 11418315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
    Menegaz BA; Cuglievan B; Benson J; Camacho P; Lamhamedi-Cherradi SE; Leung CH; Warneke CL; Huh W; Subbiah V; Benjamin RS; Patel S; Daw N; Hayes-Jordan A; Ludwig JA
    Oncologist; 2018 Mar; 23(3):360-366. PubMed ID: 29212731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Vagg RC; Ying Z; Zhang CH; Swayne LC; Vardi Y; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Jun; 38(6):858-70. PubMed ID: 9189130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
    Cremonesi M; Ferrari M; Chinol M; Stabin MG; Grana C; Prisco G; Robertson C; Tosi G; Paganelli G
    Eur J Nucl Med; 1999 Feb; 26(2):110-20. PubMed ID: 9933344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplastic small round cell tumor: from state of the art to future clinical prospects.
    Hovsepyan S; Giani C; Pasquali S; Di Giannatale A; Chiaravalli S; Colombo C; Orbach D; Bergamaschi L; Vennarini S; Gatz SA; Gasparini P; Berlanga P; Casanova M; Ferrari A
    Expert Rev Anticancer Ther; 2023 May; 23(5):471-484. PubMed ID: 37017324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.